PSG/HSG Symposium

Parkinson Study Group 24th Annual Symposium on Etiology, Pathogenesis and Treatment of Parkinson's Disease and Other Movement Disorders
Saturday, May 15, 2010 - 8:30 a.m. to 4:00 p.m.
Four Seasons Resort, Irving, Texas, USA

REGISTRAION IS NOW OPEN!

The Deadline for Receipt of Abstracts was Friday, February 5, 2010
Deadline for Receipt of Abstracts: Friday, January, 15, 2010
Late Breaking Research Deadline: Monday, February 15, 2010
Access the Call for Abstracts

NO REGISTRATION FEE OR ADVANCE REGISTRATION IS REQUIRED

Presented by the
Parkinson Study Group, Huntington Study Group, Dystonia Study Group, Myoclonus Study Group, Tourette Syndrome Study Group, Cooperative Ataxia Group, and Tremor Research Group

The Symposium will consist of invited speakers and peer-reviewed platform and poster presentations designed to communicate recent research advances, including new pharmacological and non-pharmacological treatment options, in the field of Parkinson’s disease, Huntington’s disease, ataxia, dystonia, myoclonus, Tourette’s syndrome, and other movement disorders thereby enhancing patient care. Professionals in neurology and related disciplines as well as practitioners, psychologists, educators, and researchers are invited to attend. The gaps in clinical practice we wish to address are the unmet needs pertaining to the translational and clinical evaluation, along with the care and treatment of patients and families affected by PD and other movement disorders.

Abstracts of platform and poster presentations representing original material will be published in the April 2010 issue of Movement Disorders.

At the conclusion of this session, participants should be able to: 1) Identify and describe by scholarly review, oral presentation and group discussion the current research into the diagnosis and treatment of Parkinson’s disease (PD) and other movement disorders which may be relevant to current treatment or which may lead to the development of further research protocols; 2) Distinguish and assess the important advances in research and clinical treatments relating to a Parkinson's disease and other movement disorders in terms of available treatment options or new methodologies for clinical research; 3) Explain new pharmacological and non-pharmacological treatment options available for Parkinson’s disease and other movement disorders in connection with their clinical practice or with regard to further clinical research methods; 4) Interpret the mechanisms (genetic, environmental, pathophysiology, neurobiology) linked to Parkinson’s disease and other movement disorders when assessing Parkinson's disease or other movement disorder patients or when developing new research protocols; and 5) Employ diagnostic approaches and tools available for assessing Parkinson’s disease and other movement disorders when diagnosing new patients or when conducting clinical research.

Please contact Roseanna Battista at with any questions.

More information on the 2010 PSG/HSG Symposium is available on the Parkinson Study Group (PSG) web site.


Home Clinical Research Clinical Trials/Observational Studies in Progress 2CARE COHORT CREST-E DIMOND HART HORIZON PHAROS PREDICT-HD PREQUEL RESPOND-HD Completed Clinical Trials HSG Research Sites Request for Proposals About Us HSG Overview HSG Executive Committee HSG Working Groups Standing HSG Committees Becoming an HSG Research Site Education Resources Login FAQ's Clinical Care UHDRS Links Publications News & Events Events & Upcoming Meetings PSG/HSG Symposium Huntington Disease Clinical Research Symposium Giving Contact Us	Parkinson Study Group 24th Annual Symposium on Etiology, Pathogenesis and Treatment of Parkinson's Disease and Other Movement Disorders Saturday, May 15, 2010 - 8:30 a.m. to 4:00 p.m. Four Seasons Resort, Irving, Texas, USA REGISTRAION IS NOW OPEN! The Deadline for Receipt of Abstracts was Friday, February 5, 2010 Deadline for Receipt of Abstracts: Friday, January, 15, 2010 Late Breaking Research Deadline: Monday, February 15, 2010 Access the Call for Abstracts NO REGISTRATION FEE OR ADVANCE REGISTRATION IS REQUIRED Presented by the Parkinson Study Group, Huntington Study Group, Dystonia Study Group, Myoclonus Study Group, Tourette Syndrome Study Group, Cooperative Ataxia Group, and Tremor Research Group The Symposium will consist of invited speakers and peer-reviewed platform and poster presentations designed to communicate recent research advances, including new pharmacological and non-pharmacological treatment options, in the field of Parkinson’s disease, Huntington’s disease, ataxia, dystonia, myoclonus, Tourette’s syndrome, and other movement disorders thereby enhancing patient care. Professionals in neurology and related disciplines as well as practitioners, psychologists, educators, and researchers are invited to attend. The gaps in clinical practice we wish to address are the unmet needs pertaining to the translational and clinical evaluation, along with the care and treatment of patients and families affected by PD and other movement disorders. Abstracts of platform and poster presentations representing original material will be published in the April 2010 issue of Movement Disorders. At the conclusion of this session, participants should be able to: 1) Identify and describe by scholarly review, oral presentation and group discussion the current research into the diagnosis and treatment of Parkinson’s disease (PD) and other movement disorders which may be relevant to current treatment or which may lead to the development of further research protocols; 2) Distinguish and assess the important advances in research and clinical treatments relating to a Parkinson's disease and other movement disorders in terms of available treatment options or new methodologies for clinical research; 3) Explain new pharmacological and non-pharmacological treatment options available for Parkinson’s disease and other movement disorders in connection with their clinical practice or with regard to further clinical research methods; 4) Interpret the mechanisms (genetic, environmental, pathophysiology, neurobiology) linked to Parkinson’s disease and other movement disorders when assessing Parkinson's disease or other movement disorder patients or when developing new research protocols; and 5) Employ diagnostic approaches and tools available for assessing Parkinson’s disease and other movement disorders when diagnosing new patients or when conducting clinical research. Please contact Roseanna Battista at with any questions. More information on the 2010 PSG/HSG Symposium is available on the Parkinson Study Group (PSG) web site.